Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. (Q45365194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Andrei Damyanovich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Venessa Pattullo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E Jenny Heathcote

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

25 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1028-1038

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Improved cognitive function as a consequence of hepatitis C virus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Worse quality of life in volunteer blood donors with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Evidence for a cerebral effect of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Microglial activation and its implications in the brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02549.X

10.1111/J.1478-3231.2011.02549.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21733093%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference